Process of Preparation of Quinazoline
This technology is related to process of preparing of 4-(3-chloro -4-fluorophenylamjno)-7-methoxy -6- [3-(4-morpholinyl) propoxy] quinazoline (Gefitinib). What is Novelty? The earlier technologies for preparing 4-(3-chloro-4-fluorophenylamino)-7-methoxy-6-[3-(4-morpholinyl)propoxy]-quinazoline (gefitinib) having low yield about 50% -75% whereas present technology gives high yield. In addition, has significant advantage in terms of time and cost. This technology can produce Gefitinib in less synthetic steps.
Sector: Fluid systems and components for general use
Country: India
Area of Application: medical industry, pharma industry.
Keywords: Quinazoline,AstraZeneca (Iressa),Teva,NATCO
Advantages: Non-Infringing method of producing Gefitinib. Cost Effective drug. Less production cost. High yield compared to earlier Gefitinib production methods. Huge market opportunity. FDA approval for Gefitinib.
Environmental aspects: Not Applicable
Development Status: Laboratory Model
Legal Protection: Patent in Progress
Technical specifications:
Transfer Terms: Technology Licensing
Target Countries: India
Estimated cost (US$):
Upload any relevant document:
Contact Person: SkyQuest Technology Consulting Pvt. Ltd.
Address: 501, Krishna Complex, Opp. Devashish School, Bodakdev
City: Ahmedabad
Country: India
Zip/Pin Code: 380054
Contact Technology Provider
Technology offer
Interested in this technology?
Request further information or explore potential cooperation with the technology provider.
Technology request
Can you help meet this technology need?
Share a relevant technology, expertise or partnership opportunity with APCTT.